About 1 in 5000 males are born with hemophilia, according to Steven W. Pipe, MD, a professor of pediatrics and pathology at the University of Michigan, Ann Arbor and medical director of the Pediatric Hemophilia and Coagulation Disorders Program.
About 1 in 5000 males are born with hemophilia, said Steven W. Pipe, MD, a professor of pediatrics and pathology at the University of Michigan, Ann Arbor and medical director of the Pediatric Hemophilia and Coagulation Disorders Program
Transcript
What are some current trends in hemophilia incidence?
Hemophilia is a congenital disorder. It's a defective gene for factor VIII, which is hemophilia A or defective gene for factor VIIII, which is hemophilia B. The incidence of hemophilia A and B has been quite static for decades, and it's probably because we've improved the health of carriers as well as the population itself. So, we really don't see any significant changes going forward from what we've been used to seeing over the last few years. There's 30,000-33,000 patients with hemophilia in the US, about 85% of those have hemophilia A, so a factor VIII deficiency; the others are hemophilia B. Just to give you some perspective, it's about 1 in 5000 male births affected by hemophilia. And of those, almost 50% of them are going to have the severe form of the condition.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More